Yinchiao
NDC Package 58975-022-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Yinchiao is usestemporarily relieves these symptoms due to a cold, the flu, or hay fever:minor aches and pains headachesore throatsneezingrunny noseitchy, watery eyesitching of the nose or throattemporarily reduces fever. Marketed by Tianjin Zhongxin Pharmaceutical Group Corp Ltd Longshunrong Pharmaceutical Factory, this product is identified by NDC 58975-022 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
58975-022-01
Package Description
120 TABLET, FILM COATED in 1 BOX
Product Code
58975-022
11-Digit Billing Format
58975002201
RxNorm Crosswalk
  • RxCUI: 1091008 - acetaminophen 163 MG / chlorpheniramine maleate 1 MG Oral Tablet
  • RxCUI: 1091008 - acetaminophen 162.5 MG / chlorpheniramine maleate 1 MG Oral Tablet
  • RxCUI: 1091008 - APAP 163 MG / Chlorpheniramine Maleate 1 MG Oral Tablet

Clinical Specifications

Proprietary Name
Yinchiao
Dosage Form
-
Usage Information
Usestemporarily relieves these symptoms due to a cold, the flu, or hay fever:minor aches and pains headachesore throatsneezingrunny noseitchy, watery eyesitching of the nose or throattemporarily reduces fever

Regulatory & Marketing

Labeler Name
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Longshunrong Pharmaceutical Factory
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
02-16-2011
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 58975-022-01 identifies a specific commercial package of 120 tablet, film coated in 1 box of Yinchiao, labeled by Tianjin Zhongxin Pharmaceutical Group Corp Ltd Longshunrong Pharmaceutical Factory. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Tianjin Zhongxin Pharmaceutical Group Corp Ltd Longshunrong Pharmaceutical Factory on February 16, 2011. The current certification is valid through December 31, 2017.

How is this Tianjin Zhongxin Pharmaceutical Group Corp Ltd Longshunrong Pharmaceutical Factory product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 58975002201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
58975-022-01
11-Digit CMS (5-4-2)
58975-0022-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.